108 related articles for article (PubMed ID: 6448685)
1. Radiosensitive, thymic hormone-sensitive peripheral blood suppressor cell activity in cancer patients.
Hersh EM; Patt YZ; Murphy SG; Dicke K; Zander A; Adegbite M; Goldman R
Cancer Res; 1980 Sep; 40(9):3134-40. PubMed ID: 6448685
[TBL] [Abstract][Full Text] [Related]
2. Suppressor cell activity in cancer patients: a possible role for thymic hormones.
Patt YZ; Hersh EM; Dicke K; Spitzer G; Mavligit GM
Cancer Treat Rep; 1978 Nov; 62(11):1763-8. PubMed ID: 153198
[TBL] [Abstract][Full Text] [Related]
3. Suppressor leukocytes in anergic patients with solid tumors.
Bankhurst AD; Kauffman GR; Goodwin JS; Saiki JH; Saiers JH; Williams RC
J Clin Lab Immunol; 1980 May; 3(3):159-63. PubMed ID: 6448298
[TBL] [Abstract][Full Text] [Related]
4. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
5. Maturational effects of thymic hormones on human helper and suppressor T cells: effects of FTS ('Facteur Thymique Sérique') and thymosin.
Kaufman DB
Clin Exp Immunol; 1980 Mar; 39(3):722-7. PubMed ID: 6445799
[TBL] [Abstract][Full Text] [Related]
6. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity in patients with acquired immunodeficiency syndrome (AIDS) in Israel: effects of THF, a thymic hormone in vitro.
Shohat B; Joshua H; Delpre G; Geller E; Blum I; Theodor E; Trainin N
Thymus; 1986; 8(3):151-60. PubMed ID: 2944256
[TBL] [Abstract][Full Text] [Related]
8. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
Catalona WJ; Ratliff TL; McCool RE
J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
[TBL] [Abstract][Full Text] [Related]
9. Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.
Berd D; Maguire HC; Mastrangelo MJ
Cancer Res; 1984 Mar; 44(3):1275-80. PubMed ID: 6229330
[TBL] [Abstract][Full Text] [Related]
10. Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
Somasundaram R; Advani SH; Shetye MR; Gangal SG
J Clin Lab Immunol; 1986 Jan; 19(1):43-7. PubMed ID: 2939248
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies.
Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR; Goldstein AL; Lynch K
Diagn Immunol; 1983; 1(3):168-73. PubMed ID: 6238750
[TBL] [Abstract][Full Text] [Related]
12. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
[TBL] [Abstract][Full Text] [Related]
13. [Modulation of suppressor activity by thymosin].
Cupissol D; Thierry C; Serrou B
C R Seances Soc Biol Fil; 1981; 175(2):235-41. PubMed ID: 6454471
[TBL] [Abstract][Full Text] [Related]
14. Suppressor cell numbers and activity in non-transfused renal dialysis patients.
Smith MD; Hardy G; Williams JD; Coles GA
Clin Nephrol; 1983 Sep; 20(3):130-5. PubMed ID: 6226465
[TBL] [Abstract][Full Text] [Related]
15. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(3A):1871-88. PubMed ID: 10928121
[TBL] [Abstract][Full Text] [Related]
16. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
Minassian AA; Kadagidze ZG
Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
[TBL] [Abstract][Full Text] [Related]
17. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
Dopp AC; Mutchnick MG; Goldstein AL
Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
[TBL] [Abstract][Full Text] [Related]
18. Immunological suppressor cell activity in insulin dependent diabetes.
Slater LM; Murray SL; Kershnar A; Mosier MA
J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
[TBL] [Abstract][Full Text] [Related]
19. Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.
de Galocsy C; Jenkins PJ; Mieli-Vergani G; Eddleston AL; Williams R
Clin Exp Immunol; 1981 Mar; 43(3):486-90. PubMed ID: 6456855
[TBL] [Abstract][Full Text] [Related]
20. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
